UPL Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/9gzle2h7oreijnw85kwq65fw.pdf

Key Takeaways


FY26 Guidance: The Cautious Number

Mike Frank: “You know, we just saw this past quarter, all our peers report, and for the most part, most companies were flat to down on revenue. In fact, some companies were down in the double digits. And so, the industry continues to be very challenging. Obviously, we outperformed that in our fourth quarter.”

The Balance Sheet Reset

Anand Vora: “Non-recourse factoring, something which is referred to every now and then, was at similar levels as that of the previous year. In other words, we have not increased non-recourse factoring, to increase our cash flow, as has been often spoken about in the previous years.”

Differentiated Portfolio: The Margin Story

Mike Frank: “the margin profile, on average, is 600 to 1,000 basis points higher than the post-patent segment”

Advanta: The Quietly Scaled Seed Platform

Bhupen Dubey: “I do believe that the year is not far when we can also say that Advanta is one of the top 5 global seeds company.”

Superform: The Specialty Chemistry Third Leg

Raj Tiwari: “The purpose is to reinvent the chemistry, as world's most powerful force for bringing that positive change, not only for our customer, but for the community, for the shareholders, for the, employees, for every soul, which we touch with”

Regional & Business Unit Dynamics

Region / UnitQ4 TrendCommentary
North America▲ Strong84% revenue growth, 64% volume growth; channel inventories and rebates back to normal; strong herbicide portfolio (clethodim, s-metolachlor, metribuzin). Year-ago Q4 was weak, so growth rates need a longer time horizon to assess.
Europe▲ StrongRevenue up 25% on favourable weather, strong fungicide volumes (Proxanil®, captan), and strong biocontrol/biostimulant growth.
Latin America▬ MixedBrazil volumes led by mancozeb and acephate products; Mexico and Central America outperformed. Argentina was very challenging all year, including Q4, but is expected to start turning around in FY26.
Rest of World▲ Modest3% volume-led growth across Asia-Pacific and Africa.
UPL SAS (India)▲ StrongStrongest quarter; big revenue jump on volumes and rabi liquidations in sugarcane and pulses. Full-year herbicide segment performed exceedingly well; share of strategy crops (corn, rice, sugarcane) offset cotton decline.
Advanta▲ StrongQ4 revenue up 37% on advance cash collection from Thailand and India; corn demand robust.
Superform▬ StableRevenue >₹10,000 cr, 6% growth; specialty chemicals grew 24%; EBITDA de-grew 7% on product mix.
Ashish Dobhal: “We can very confidently say that this year, whatever we've done is not a flash in the pan. This is a business which is with a very strong core, and is future ready. And we're trying to develop a culture where excellence is a habit.”

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth4% to 8% growth bandFY26 full year
EBITDA growth10% to 14% growthFY26 full year
H1 trajectorySubdued revenue; global crop protection margins similar to Q4 levelsH1 FY26
New product revenueOver $130 mn from 20+ new productsFY26
Differentiated/sustainable mixMove toward 50-50 mix vs post-patentFY27–FY28 range
Natural plant protection revenue$700 mnBy FY27
Innovation rate17.5% (FY26), rising to mid-20s (24–25%)FY26; end of decade
India innovation rateIn excess of 35%Within three years
Rights issue balance callBalance 50% calledSometime in H1 FY26
Working capital daysMaintain current levels; mid-60s modelledOngoing
Argentina turnaroundExpected to start turning aroundHeading into FY26
Perpetual bond decisionBoard meeting to decide roll-over or redeemShort notice; decision shortly

Key Metrics

MetricQ4 FY25
Revenue₹15,570 cr, +11% YoY, almost entirely volume-led
Contribution margin38.0%, +870 bps YoY
EBITDA₹3,240 cr, +68% YoY
EBITDA margin20.8%, +700 bps YoY
PAT (adjusted)₹900 cr, vs ₹40 cr in Q4 FY24
Revenue growth guidance (FY26)4% to 8%, with H1 expected subdued
EBITDA growth guidance (FY26)10% to 14%
Global crop protection revenue growth+18% YoY, volume-led across North America and Europe
Global crop protection contribution margin+900 bps YoY
Global crop protection EBITDA margin improvement+1,000 bps YoY
North America revenue growth+84% YoY, on 64% volume growth
Europe revenue growth+25% YoY, driven by fungicides and biocontrol
Differentiated and sustainable product volume growth+23% YoY
Differentiated and sustainable mix38% of products, vs 35% in FY24
New product launches revenue$93 mn, exceeding $85 mn target, ~2% of total revenue
UPL SAS revenue₹680 cr, +57% YoY
UPL SAS EBITDA₹90 cr, vs −₹40 cr in Q4 FY24
UPL SAS contribution margin27.8%, vs 5.7% in Q4 FY24
Advanta revenue growth+37% YoY, driven by corn demand in Thailand and India
Advanta EBITDA growth+160% YoY
Net debt₹13,860 cr ($1.62 bn), reduced by ₹8,330 cr ($1.04 bn) YoY
Net debt to EBITDA1.7x, significant reduction YoY
Net working capital days53 days, reduced by 33 days YoY
Operating free cash flow$530 mn, exceeded guidance of $300–400 mn